In addition, the univariate and multivariate survival analyses (Cox proportional hazards regression model) were used to further assess whether LUCAT1 expression can be a novel prognostic or progression marker for NSCLC patients. Here, LUCAT1 is linked to non-small cell lung carcinoma.